期刊文献+

RNAi沉默SSP411基因对人胆管癌HuCCA-1细胞增殖的影响

Effects of RNA interference targeting SSP411 gene on proliferation of human cholangiocarcinoma HuCCA-1 cells
原文传递
导出
摘要 目的研究RNA干扰(RNAi)对SSP411进行基因沉默后胆管癌细胞体外增殖的变化。方法构建针对SSP411的RNAi质粒,将离体培养的胆管癌HuCCA-1细胞分为阴性对照(C)组、shRNA-SSP411-1转染(A1)组和shRNA-SSP411-2转染(A2)组。采用RT-PCR和Western blot法分别检测HuCCA-1细胞中SSP411mRNA和蛋白表达;通过MTT实验、平板克隆形成和软琼脂克隆球形成能力检测,观察目的基因被下调后细胞增殖能力的变化。结果 A1、A2组细胞的SSP411mRNA和蛋白表达较C组明显降低。与C组相比,A1、A2组胆管癌细胞生长被显著抑制(P<0.01);A1、A2组平板克隆形成数目低于C组[(66±18)个、(70±17)个vs.(115±16)个](P<0.01或P<0.05);与C组相比,A1、A2组软琼脂克隆球数目显著下降[(96±29)个vs.(53±9)个、(43±13)个](P<0.05)。结论 RNAi介导的SSP411基因沉默可抑制人胆管癌HuCCA-1细胞的增殖能力;SSP411可作为胆管癌治疗的新靶点。 Objective To investigate the effects of RNA interference(RNAi) targeting SSP411 gene on the proliferation of human cholangiocarcinoma cells in vitro. Methods Two RNAi vectors against SSP411 gene were constructed. HuCCA-1 cells were divided into three groups of C(negative control), A1 (stably transfected with shRNA-SSP411-1 vector) and A2 (stably transfected with shRNA-SSP411-2 vector). The expressions of SSP411 mRNA and protein were detected by RT-PCR and Western blot, respectively. The proliferation of HuCCA-1 cells after RNAi was assessed by MTT, colony forming ability and soft agar gel colony forming ability assays. Results The expressions of SSP411 mRNA and protein in groups of A1 and A2 were lower than those in group C. The cell growth was significantly inhibited in groups of A1 and A2, compared with group C(P〈0. 01). The numbers of colony formation in groups of A1 and A2 were lower than those in group C[(66±18) pieces and (70±17) pieces vs. (115±16) pieces] (P〈0. 01 or P〈0. 05). Similarly, compared with group C, the numbers of clone balls in groups of A1 and A2 were obviously decreased[(96±29) pieces vs. (53+9) pieces and (43±13) pieces~]P〈0. 05). Conclusion RNAi-mediated SSP411 gene silencing can inhibit the proliferation of HuCCA-1 cells. The SSP411 may be taken as a potential target for cholangiocarcinoma therapy.
出处 《江苏医药》 CAS 北大核心 2013年第8期888-891,共4页 Jiangsu Medical Journal
基金 南京医科大学校基金重点项目(2012NJMU087)
关键词 胆管癌 RNA干扰 SSP411 Cholangiocarcinoma RNA interference SSP411
  • 相关文献

参考文献9

  • 1Tyson GL, El-Scrag HB. Risk factors for cholangiocarcinoma [J]. Hepatology, 2011,54(1) : 173-184.
  • 2Blechacz BR, Gores GJ. Cholangiocarcinoma[J]. Clin Liver Dis, 2008,12(1) : 131-150.
  • 3Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special refeenee to postoperative morbidity and mortality [ J ]. J Hepatobiliary Pancreat Sci, 2010,17 (4) : 455-462.
  • 4Lee SG, Song GW, Hwang S, et al. Surgical treatment of hilar cholangiocareinoma in the new era.. the Asan experience[J]. J Hepatobiliary Pancreat Sci, 2010,17(4) : 476-489.
  • 5薛志东,李国利.肿瘤-睾丸基因研究进展[J].国外医学(肿瘤学分册),2005,32(6):432-435. 被引量:2
  • 6Sift HJ,Wu AZ, Santos M, et al. Cloning and characterization of rat spermatid protein SSP411.-a thioredoxin-like protein[J]. J Androl,2004,25(4) :479-493.
  • 7Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature, 1998,391 (6669 ) : 806-811.
  • 8Elhashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21- nucleotide RNAs mediate RNA interference in cultured mammalian cells[J]. Nature, 2001,411 (6836) : 494-498.
  • 9Hannon GJ. RNA interferenceEJ]. Nature, 2002, 418 (6894) : 244-251.

二级参考文献20

  • 1Gure AO, Stockert E, Arden KC, et al. CT10: a new cancer-testis(CT) antigen homologous to CT7 and the MACE family,identified by representational-difference analysis. Int J Cancer,2000,85(5) :726-732.
  • 2Martelange V, De Smet C, De Plaen E, et al. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res,2000 ,60(14):3848-3855.
  • 3Zendman A J, Cornelissen IM, Weidle UH, et al. CTp11, a novel member of the family of human cancer/testis antigens. Cancer Res, 1999,59 (24) :6223-6229.
  • 4de Wit NJ,Weidle UH, Ruiter DJ, et al. Expression profiling of MMA-1 a and splice variant MMA-1 b:new cancer/testis antigens identified in human melanoma. Int J Cancer,2002,98(4) :547-553.
  • 5Scanlan MJ, Altorki NK, Gure AO, et al. Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene,CT9. Cancer Lett,2000,150(2) :155-164.
  • 6Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review,standardization, and commentary. Cancer Immun ,2004,4 : 1.
  • 7Scanlan M J, Gure AO, Jungbluth AA, et al. Cancer/testis antigens:an expanding family of targets for cancer immunotherapy. Immunol Rev,2002,188:22-32.
  • 8Sharma P, Gnjatic S, Jungbluth AA, et al. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Cancer Immun ,2003,3 : 19.
  • 9Scanlan M J, Gordon CM, Williamson B, et al. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer,2002,98(4):485-492.
  • 10Koslowski M ,Tureci O, Bell C, et al. Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res,2002,62 (22) :6750-6755.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部